Hims launches telehealth testosterone replacement therapy for men

Telehealth giant Hims has launched a testosterone replacement therapy service for cisgender men, offering two injectable treatments and an oral pill after an at-home blood test. The company, which serves 2.9 million customers since its 2017 launch, requires a video consultation with a clinician because testosterone is a controlled substance.

• Hims offers two types of testosterone injections plus an oral pill option
• Patients use a wearable Tasso microneedle device to collect blood at home
• The lab panel covers 21 biomarkers, including triglycerides and thyroid hormones
• Hims has served 2.9 million customers since launching in 2017